Your activity: 36 p.v.
your limit has been reached. plz Donate us to allow your ip full access, Email: sshnevis@outlook.com

Reversing anticoagulation in warfarin-associated bleeding

Reversing anticoagulation in warfarin-associated bleeding
Management option Time to anticoagulation reversal Comments and cautions
Discontinuing warfarin therapy 5 to 14 days Five days is typical for patients with an INR in the therapeutic range
Vitamin K* 6 to 24 hours to correct the INR, longer to fully reverse anticoagulation

Recovery of factors X and II (prothrombin) takes longer than 24 hours

Risk of anaphylaxis with intravenous injection

Impaired response to warfarin lasting up to one week may occur after large doses (ie, >5 mg)
Fresh frozen plasma Depends on the time it takes to complete the infusion; typically 12 to 32 hours for complete reversal

Effect is transient and concomitant vitamin K must be administered

Potential for volume overload (2 to 4 L to normalize INR)

Potential for TRALI

Potential for viral transmission
Prothrombin complex concentrate 15 minutes after 10-minute to 1-hour infusion

Effect is transient, and concomitant vitamin K must be administered; limited availability

Cost

Variable factor VII content depending on the product: a 4-factor PCC is preferred

Potentially prothrombotic
Recombinant factor VIIa 15 minutes after bolus infusion

Effect is transient, and concomitant vitamin K must be administered

Cost

Potentially prothrombotic
Please refer to the UpToDate topic on warfarin reversal in intracerebral hemorrhage for further details of management.
INR: international normalized ratio; TRALI: transfusion-related acute lung injury; PCC: prothrombin complex concentrate.
* A total of 10 mg intravenously by slow infusion given over 10 minutes.
Adapted with permission from: Aguilar MI, Hart RG, Kase CS, et al. Treatment of warfarin-associated intercerebral hemorrhage: Literature review and expert opinion. Mayo Clin Proc 2007; 82:82. Copyright © 2007 Dowden Health Media.
Graphic 79151 Version 16.0